EMEA (Europe, Middle East and Africa) Oligonucleotide Synthesis Market Report 2017

August 2017 | 114 pages | ID: E9B7321698EEN
QYResearch

Abstracts

In this report, the EMEA Oligonucleotide Synthesis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oligonucleotide Synthesis for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oligonucleotide Synthesis market competition by top manufacturers/players, with Oligonucleotide Synthesis sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Genescript
• GeneArt (Thermofischer)
• IDT
• DNA 2.0 (ATUM)
• OriGene
• BBI
• Genewiz
• Eurofins Genomics
• Gene Oracle
• SBS Genetech
• Bio Basic

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Primers
• Probes
• Intermediate-scale Synthesis Oligos
• Large-scale Synthesis Oligos
• Linkers and Adaptors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oligonucleotide Synthesis for each application, including

• Commercial
• Academic Research

Contents

EMEA (Europe, Middle East and Africa) Oligonucleotide Synthesis Market Report 2017

1 OLIGONUCLEOTIDE SYNTHESIS OVERVIEW

1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Classification of Oligonucleotide Synthesis
  1.2.1 EMEA Oligonucleotide Synthesis Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Oligonucleotide Synthesis Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Primers
  1.2.4 Probes
  1.2.5 Intermediate-scale Synthesis Oligos
  1.2.6 Large-scale Synthesis Oligos
  1.2.7 Linkers and Adaptors
1.3 EMEA Oligonucleotide Synthesis Market by Application/End Users
  1.3.1 EMEA Oligonucleotide Synthesis Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Commercial
  1.3.3 Academic Research
1.4 EMEA Oligonucleotide Synthesis Market by Region
  1.4.1 EMEA Oligonucleotide Synthesis Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oligonucleotide Synthesis (2012-2022)
  1.5.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate (2012-2022)

2 EMEA OLIGONUCLEOTIDE SYNTHESIS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Oligonucleotide Synthesis Market Competition by Players/Manufacturers
  2.1.1 EMEA Oligonucleotide Synthesis Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Oligonucleotide Synthesis Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Oligonucleotide Synthesis Sale Price by Players (2012-2017)
2.2 EMEA Oligonucleotide Synthesis (Volume and Value) by Type/Product Category
  2.2.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Oligonucleotide Synthesis Sale Price by Type (2012-2017)
2.3 EMEA Oligonucleotide Synthesis (Volume) by Application
2.4 EMEA Oligonucleotide Synthesis (Volume and Value) by Region
  2.4.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Oligonucleotide Synthesis Sales Price by Region (2012-2017)

3 EUROPE OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Oligonucleotide Synthesis Sales and Value (2012-2017)
  3.1.1 Europe Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
3.2 Europe Oligonucleotide Synthesis Sales and Market Share by Type
3.3 Europe Oligonucleotide Synthesis Sales and Market Share by Application
3.4 Europe Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Oligonucleotide Synthesis Sales Volume by Countries (2012-2017)
  3.4.2 Europe Oligonucleotide Synthesis Revenue by Countries (2012-2017)
  3.4.3 Germany Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  3.4.4 France Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  3.4.5 UK Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  3.4.6 Russia Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  3.4.7 Italy Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Oligonucleotide Synthesis Sales and Value (2012-2017)
  4.1.1 Middle East Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
4.2 Middle East Oligonucleotide Synthesis Sales and Market Share by Type
4.3 Middle East Oligonucleotide Synthesis Sales and Market Share by Application
4.4 Middle East Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Oligonucleotide Synthesis Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Oligonucleotide Synthesis Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  4.4.4 Israel Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  4.4.5 UAE Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  4.4.6 Iran Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)

5 AFRICA OLIGONUCLEOTIDE SYNTHESIS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Oligonucleotide Synthesis Sales and Value (2012-2017)
  5.1.1 Africa Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
5.2 Africa Oligonucleotide Synthesis Sales and Market Share by Type
5.3 Africa Oligonucleotide Synthesis Sales and Market Share by Application
5.4 Africa Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Oligonucleotide Synthesis Sales Volume by Countries (2012-2017)
  5.4.2 Africa Oligonucleotide Synthesis Revenue by Countries (2012-2017)
  5.4.3 South Africa Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)

6 EMEA OLIGONUCLEOTIDE SYNTHESIS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Genescript
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genescript Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GeneArt (Thermofischer)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GeneArt (Thermofischer) Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 IDT
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IDT Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 DNA 2.0 (ATUM)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 OriGene
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 OriGene Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BBI
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BBI Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Genewiz
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Genewiz Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eurofins Genomics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eurofins Genomics Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gene Oracle
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gene Oracle Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 SBS Genetech
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Oligonucleotide Synthesis Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 SBS Genetech Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Bio Basic

7 OLIGONUCLEOTIDE SYNTHESIS MANUFACTURING COST ANALYSIS

7.1 Oligonucleotide Synthesis Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oligonucleotide Synthesis

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oligonucleotide Synthesis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OLIGONUCLEOTIDE SYNTHESIS MARKET FORECAST (2017-2022)

11.1 EMEA Oligonucleotide Synthesis Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Oligonucleotide Synthesis Price and Trend Forecast (2017-2022)
11.2 EMEA Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oligonucleotide Synthesis Sales Forecast by Type (2017-2022)
11.7 EMEA Oligonucleotide Synthesis Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oligonucleotide Synthesis
Figure EMEA Oligonucleotide Synthesis Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Oligonucleotide Synthesis Sales Volume Market Share by Type (Product Category) in 2016
Figure Primers Product Picture
Figure Probes Product Picture
Figure Intermediate-scale Synthesis Oligos Product Picture
Figure Large-scale Synthesis Oligos Product Picture
Figure Linkers and Adaptors Product Picture
Figure EMEA Oligonucleotide Synthesis Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Oligonucleotide Synthesis by Application in 2016
Figure Commercial Examples
Figure Academic Research Examples
Figure EMEA Oligonucleotide Synthesis Market Size (Million USD) by Region (2012-2022)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oligonucleotide Synthesis Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales Share by Players (2012-2017)
Figure 2016 Oligonucleotide Synthesis Sales Share by Players
Figure 2017 Oligonucleotide Synthesis Sales Share by Players
Figure EMEA Oligonucleotide Synthesis Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) by Players (2012-2017)
Table EMEA Oligonucleotide Synthesis Revenue Share by Players (2012-2017)
Table 2016 EMEA Oligonucleotide Synthesis Revenue Share by Players
Table 2017 EMEA Oligonucleotide Synthesis Revenue Share by Players
Table EMEA Oligonucleotide Synthesis Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales Share by Type (2012-2017)
Figure Sales Market Share of Oligonucleotide Synthesis by Type (2012-2017)
Figure EMEA Oligonucleotide Synthesis Sales Market Share by Type (2012-2017)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oligonucleotide Synthesis Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oligonucleotide Synthesis by Type in 2016
Table EMEA Oligonucleotide Synthesis Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales Share by Application (2012-2017)
Figure Sales Market Share of Oligonucleotide Synthesis by Application (2012-2017)
Figure EMEA Oligonucleotide Synthesis Sales Market Share by Application in 2016
Table EMEA Oligonucleotide Synthesis Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Oligonucleotide Synthesis Sales Share by Region (2012-2017)
Figure Sales Market Share of Oligonucleotide Synthesis by Region (2012-2017)
Figure EMEA Oligonucleotide Synthesis Sales Market Share in 2016
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oligonucleotide Synthesis Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oligonucleotide Synthesis by Region (2012-2017)
Figure EMEA Oligonucleotide Synthesis Revenue Market Share Regions in 2016
Table EMEA Oligonucleotide Synthesis Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
Table Europe Oligonucleotide Synthesis Sales (K Units) by Type (2012-2017)
Table Europe Oligonucleotide Synthesis Market Share by Type (2012-2017)
Figure Europe Oligonucleotide Synthesis Market Share by Type in 2016
Table Europe Oligonucleotide Synthesis Sales (K Units) by Application (2012-2017)
Table Europe Oligonucleotide Synthesis Market Share by Application (2012-2017)
Figure Europe Oligonucleotide Synthesis Market Share by Application in 2016
Table Europe Oligonucleotide Synthesis Sales (K Units) by Countries (2012-2017)
Table Europe Oligonucleotide Synthesis Sales Market Share by Countries (2012-2017)
Figure Europe Oligonucleotide Synthesis Sales Market Share by Countries (2012-2017)
Figure Europe Oligonucleotide Synthesis Sales Market Share by Countries in 2016
Table Europe Oligonucleotide Synthesis Revenue (Million USD) by Countries (2012-2017)
Table Europe Oligonucleotide Synthesis Revenue Market Share by Countries (2012-2017)
Figure Europe Oligonucleotide Synthesis Revenue Market Share by Countries (2012-2017)
Figure Europe Oligonucleotide Synthesis Revenue Market Share by Countries in 2016
Figure Germany Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure France Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure UK Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oligonucleotide Synthesis Sales (K Units) by Type (2012-2017)
Table Middle East Oligonucleotide Synthesis Market Share by Type (2012-2017)
Figure Middle East Oligonucleotide Synthesis Market Share by Type (2012-2017)
Table Middle East Oligonucleotide Synthesis Sales (K Units) by Applications (2012-2017)
Table Middle East Oligonucleotide Synthesis Market Share by Applications (2012-2017)
Figure Middle East Oligonucleotide Synthesis Sales Market Share by Application in 2016
Table Middle East Oligonucleotide Synthesis Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Oligonucleotide Synthesis Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oligonucleotide Synthesis Sales Volume Market Share by Countries in 2016
Table Middle East Oligonucleotide Synthesis Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oligonucleotide Synthesis Revenue Market Share by Countries (2012-2017)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share by Countries (2012-2017)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oligonucleotide Synthesis Sales (K Units) by Type (2012-2017)
Table Africa Oligonucleotide Synthesis Sales Market Share by Type (2012-2017)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Type (2012-2017)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Type in 2016
Table Africa Oligonucleotide Synthesis Sales (K Units) by Application (2012-2017)
Table Africa Oligonucleotide Synthesis Sales Market Share by Application (2012-2017)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Application (2012-2017)
Table Africa Oligonucleotide Synthesis Sales Volume (K Units) by Countries (2012-2017)
Table Africa Oligonucleotide Synthesis Sales Market Share by Countries (2012-2017)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Countries (2012-2017)
Figure Africa Oligonucleotide Synthesis Sales Market Share by Countries in 2016
Table Africa Oligonucleotide Synthesis Revenue (Million USD) by Countries (2012-2017)
Table Africa Oligonucleotide Synthesis Revenue Market Share by Countries (2012-2017)
Figure Africa Oligonucleotide Synthesis Revenue Market Share by Countries (2012-2017)
Figure Africa Oligonucleotide Synthesis Revenue Market Share by Countries in 2016
Figure South Africa Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Table Genescript Oligonucleotide Synthesis Basic Information List
Table Genescript Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genescript Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Genescript Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure Genescript Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table GeneArt (Thermofischer) Oligonucleotide Synthesis Basic Information List
Table GeneArt (Thermofischer) Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GeneArt (Thermofischer) Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure GeneArt (Thermofischer) Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure GeneArt (Thermofischer) Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table IDT Oligonucleotide Synthesis Basic Information List
Table IDT Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IDT Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure IDT Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure IDT Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table DNA 2.0 (ATUM) Oligonucleotide Synthesis Basic Information List
Table DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure DNA 2.0 (ATUM) Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table OriGene Oligonucleotide Synthesis Basic Information List
Table OriGene Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OriGene Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure OriGene Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure OriGene Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table BBI Oligonucleotide Synthesis Basic Information List
Table BBI Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BBI Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure BBI Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure BBI Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table Genewiz Oligonucleotide Synthesis Basic Information List
Table Genewiz Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genewiz Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Genewiz Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure Genewiz Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table Eurofins Genomics Oligonucleotide Synthesis Basic Information List
Table Eurofins Genomics Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eurofins Genomics Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Eurofins Genomics Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure Eurofins Genomics Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table Gene Oracle Oligonucleotide Synthesis Basic Information List
Table Gene Oracle Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gene Oracle Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure Gene Oracle Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure Gene Oracle Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table SBS Genetech Oligonucleotide Synthesis Basic Information List
Table SBS Genetech Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SBS Genetech Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2012-2017)
Figure SBS Genetech Oligonucleotide Synthesis Sales Market Share in EMEA (2012-2017)
Figure SBS Genetech Oligonucleotide Synthesis Revenue Market Share in EMEA (2012-2017)
Table Bio Basic Oligonucleotide Synthesis Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oligonucleotide Synthesis
Figure Manufacturing Process Analysis of Oligonucleotide Synthesis
Figure Oligonucleotide Synthesis Industrial Chain Analysis
Table Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2016
Table Major Buyers of Oligonucleotide Synthesis
Table Distributors/Traders List
Figure EMEA Oligonucleotide Synthesis Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oligonucleotide Synthesis Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oligonucleotide Synthesis Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oligonucleotide Synthesis Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oligonucleotide Synthesis Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Oligonucleotide Synthesis Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oligonucleotide Synthesis Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oligonucleotide Synthesis Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oligonucleotide Synthesis Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Oligonucleotide Synthesis Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources